Table 1 Baseline clinicopathological features of enrolled patients
Variables | |
|---|---|
Age (median, range) | 63.5 (35–82) |
Sex (%) | |
Female | 5 (15.6) |
Male | 27 (84.4) |
Size of metastasis (cm; median, range) | 3.5 (1–10) |
Interval: primary diagnosis to adrenalectomy (months; median, range) | 8.8 (0–93.8) |
Intent to treat (%) | |
Palliative | 10 (31.3) |
Cure | 22 (68.8) |
Site of primary tumor (%) | |
Glottis | 1 (3.1) |
Esophagus | 1 (3.1) |
Colon | 4 (12.5) |
Liver | 5 (15.6) |
Stomach | 3 (9.4) |
Kidney | 4 (12.5) |
Lung | 11 (34.4) |
Cervix | 1 (3.1) |
Pancreas | 1 (3.1) |
Ovary | 1 (3.1) |
Site of metastasis (%) | |
Single | 14 (43.8) |
Both | 5 (15.6) |
Adrenal + other site | 13 (40.6) |
Previous metastasectomy | |
No | 30 (93.8) |
Yes | 2 (6.3) |
Interval: primary diagnosis to adrenalectomy (%) | |
≥6 months (metachronous) | 13 (40.6) |
<6 months (synchronous) | 19 (59.4) |
ECOG-PS (%) | |
0 | 5 (15.6) |
1 | 23 (71.9) |
2 | 4 (12.5) |
Operative method (%) | |
Open | 20 (62.5) |
Laparoscopic | 12 (37.5) |
Recurrence after adrenalectomy (%) | |
No | 12 (37.5) |
Yes | 20 (62.5) |
C-reactive protein (mg/dl,%) | |
≤1.0 | 11 (34.4) |
>1 | 21 (65.2) |
Albumin (g/dl,%) | |
<3.5 | 12 (37.5) |
≥3.5 | 20 (62.5) |
GPS (%) | |
0 | 10 (31.3) |
1 | 11 (34.4) |
2 | 11 (34.4) |